Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice
- PMID: 16791898
- DOI: 10.1002/eji.200535734
Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice
Abstract
Mouse follicular B cells express TLR9 and respond vigorously to stimulation with single-stranded CpG-oligodeoxynucleotides (ODN). Surprisingly, follicular B cells do not respond to direct stimulation with other TLR9 ligands, such as bacterial DNA or class A(D) CpG-ODN capable of forming higher-order structures, unless other cell types are present. Here, we show that priming with interferons or with B cell-activating factor, or simultaneous co-engagement of the B cell receptor for antigen (BCR), can overcome this unresponsiveness. The effect of interferons occurs at the transcriptional level and is mediated through an autocrine/paracrine loop, which is dependent on IRF-1, IL-6 and IL-12 p40. We hypothesize that the lack of bystander activation of follicular B cells with more complex CpG ligands may be an important safety mechanism for avoiding autoimmunity. This will prevent resting B cells from responding to foreign or self-derived hypomethylated double-stranded CpG ligands unless these ligands are either delivered through the B cell receptor or under conditions where B cells are simultaneously co-engaged by activated plasmacytoid dendritic cells or TH1 cells. A corollary is that the heightened responsiveness of lupus B cells to TLR9-induced stimulation cannot be ascribed to unprimed follicular B cells, but is rather mediated by hypersensitive marginal zone B cells.
Similar articles
-
Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.J Leukoc Biol. 2004 Sep;76(3):585-93. doi: 10.1189/jlb.0104034. Epub 2004 Jun 24. J Leukoc Biol. 2004. PMID: 15218053
-
Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.J Immunol. 2005 Feb 15;174(4):2429-34. doi: 10.4049/jimmunol.174.4.2429. J Immunol. 2005. PMID: 15699180
-
Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.Eur J Immunol. 2007 Jul;37(7):1785-95. doi: 10.1002/eji.200636800. Eur J Immunol. 2007. PMID: 17557373
-
Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.Vet Immunol Immunopathol. 2005 Oct 18;108(1-2):11-6. doi: 10.1016/j.vetimm.2005.07.012. Vet Immunol Immunopathol. 2005. PMID: 16098606 Review.
-
TLR9 as a key receptor for the recognition of DNA.Adv Drug Deliv Rev. 2008 Apr 29;60(7):795-804. doi: 10.1016/j.addr.2007.12.004. Epub 2008 Jan 3. Adv Drug Deliv Rev. 2008. PMID: 18262306 Review.
Cited by
-
Toll-like receptors in systemic autoimmune disease.Nat Rev Immunol. 2006 Nov;6(11):823-35. doi: 10.1038/nri1957. Nat Rev Immunol. 2006. PMID: 17063184 Free PMC article. Review.
-
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.Ann Rheum Dis. 2012 Mar;71(3):463-8. doi: 10.1136/annrheumdis-2011-200463. Epub 2011 Nov 16. Ann Rheum Dis. 2012. PMID: 22088620 Free PMC article.
-
Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9.Int Immunopharmacol. 2011 Aug;11(8):1032-7. doi: 10.1016/j.intimp.2011.02.023. Epub 2011 Mar 2. Int Immunopharmacol. 2011. PMID: 21376154 Free PMC article.
-
Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.Clin Exp Immunol. 2010 Aug;161(2):208-22. doi: 10.1111/j.1365-2249.2010.04176.x. Epub 2010 May 7. Clin Exp Immunol. 2010. PMID: 20456414 Free PMC article. Review.
-
Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.Mediators Inflamm. 2010;2010:986596. doi: 10.1155/2010/986596. Epub 2010 May 18. Mediators Inflamm. 2010. PMID: 20490286 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases